Literature DB >> 30170181

Feminization imprinted by developmental growth hormone.

Sarmistha Banerjee1, Rajat K Das1, Bernard H Shapiro2.   

Abstract

Previously, we identified early developmental exposure to growth hormone (GH) as the requisite organizer responsible for programming the masculinization of the hepatic cytochromes P450 (CYP)-dependent drug metabolizing enzymes (Das et al., 2014, 2017). In spite of the generally held dogma that mammalian feminization requires no hormonal imprinting, numerous reports that the sex-dependent regulation and expression of hepatic CYPs in females are permanent and irreversible would suggest otherwise. Consequently, we selectively blocked GH secretion in a cohort of newborn female rats, some of whom received concurrent GH replacement or GH releasing factor. As adults, the feminine circulating GH profile was restored in the treated animals. Two categories of CYPs were measured. The principal and basically female specific CYP2C12 and CYP2C7; both completely and solely dependent on the adult feminine continuous GH profile for expression, and the female predominant CYP2C6 and CYP2E1 whose expression is maximum in the absence of plasma GH, suppressed by the feminine GH profile but more so by the masculine episodic GH profile. Our findings indicate that early developmental exposure to GH imprints the inchoate CYP2C12 and CYP2C7 in the differentiating liver to be solely dependent on the feminine GH profile for expression in the adult female. In contrast, adult expression of CYP2C6 and CYP2E1 in the female rat appears to require no GH imprinting.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytochromes P450; Development; Feminization; Growth hormone; Imprinting; Sexual dimorphism

Mesh:

Substances:

Year:  2018        PMID: 30170181      PMCID: PMC6263729          DOI: 10.1016/j.mce.2018.08.011

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  52 in total

1.  Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men.

Authors:  Chellappagounder Thangavel; Ettickan Boopathi; Bernard H Shapiro
Journal:  Endocrinology       Date:  2011-09-27       Impact factor: 4.736

2.  Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate.

Authors:  J W Olney
Journal:  Science       Date:  1969-05-09       Impact factor: 47.728

3.  Middle-age alterations in the sexually dimorphic plasma growth hormone profiles: involvement of growth hormone-releasing factor and effects on cytochrome p450 expression.

Authors:  Ravindra N Dhir; Wojciech Dworakowski; Bernard H Shapiro
Journal:  Drug Metab Dispos       Date:  2002-02       Impact factor: 3.922

4.  Growth hormone regulation of the cytochrome P-450IIC subfamily in the rat: inductive, repressive, and transcriptional effects on P-450f (IIC7) and P-450PB1 (IIC6) gene expression.

Authors:  S Westin; A Ström; J A Gustafsson; P G Zaphiropoulos
Journal:  Mol Pharmacol       Date:  1990-08       Impact factor: 4.436

5.  Sexually dimorphic regulation of hepatic isoforms of human cytochrome p450 by growth hormone.

Authors:  Ravindra N Dhir; Wojciech Dworakowski; Chellappagounder Thangavel; Bernard H Shapiro
Journal:  J Pharmacol Exp Ther       Date:  2005-09-13       Impact factor: 4.030

6.  Gender, age and dose effects of neonatally administered aspartate on the sexually dimorphic plasma growth hormone profiles regulating expression of the rat sex-dependent hepatic CYP isoforms.

Authors:  A K Agrawal; B H Shapiro
Journal:  Drug Metab Dispos       Date:  1997-11       Impact factor: 3.922

7.  Irreversible suppression of growth hormone-dependent cytochrome P450 2C11 in adult rats neonatally treated with monosodium glutamate.

Authors:  B H Shapiro; N A Pampori; P A Ram; D J Waxman
Journal:  J Pharmacol Exp Ther       Date:  1993-05       Impact factor: 4.030

8.  Influence of endogenous somatostatin on growth hormone and thyrotropin secretion in neonatal rats.

Authors:  C Oliver; P Giraud; J C Lissitzky; J Cote; F Boudouresque; P Gillioz; B Conte-Devolx
Journal:  Endocrinology       Date:  1982-03       Impact factor: 4.736

9.  Noncanonical suppression of GH-dependent isoforms of cytochrome P450 by the somatostatin analog octreotide.

Authors:  Rajat Kumar Das; Sarmistha Banerjee; Bernard H Shapiro
Journal:  J Endocrinol       Date:  2013-01-02       Impact factor: 4.286

10.  Human pancreatic growth hormone (GH)-releasing hormone stimulates GH synthesis and release in infant rats. An in vivo study.

Authors:  S G Cella; V Locatelli; V de Gennaro; R Puggioni; C Pintor; E E Müller
Journal:  Endocrinology       Date:  1985-02       Impact factor: 4.736

View more
  2 in total

1.  Impact of 3D genome organization, guided by cohesin and CTCF looping, on sex-biased chromatin interactions and gene expression in mouse liver.

Authors:  Bryan J Matthews; David J Waxman
Journal:  Epigenetics Chromatin       Date:  2020-07-17       Impact factor: 4.954

2.  Early expression of requisite developmental growth hormone imprinted cytochromes P450 and dependent transcription factors.

Authors:  Sarmistha Banerjee; Allison M Hayes; Bernard H Shapiro
Journal:  Endocr Connect       Date:  2021-09-20       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.